in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
AstraZeneca completes acquisition of Sumitomo's stake in AstraZeneca Japan
9:19 AM MDT | March 26, 2014 | Natasha Alperowicz
AstraZeneca announced today that it has completed the purchase of Sumitomo Chemical’s remaining shares in AstraZeneca K.K. (Osaka). Sumitomo announced last month that it planned to sell its 20% stake in AstraZeneca K.K. The purchase was valued at approximately ¥10 billion ($102 million) and gives AstraZeneca full control of AstraZeneca K.K. “Our decision to gain full control of AstraZeneca K.K. reinforces our focus on Japan as a key growth platform,” says Marc Dunoyer, CEO of AstraZeneca. Japan is the world's...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee